InvestorsHub Logo
Followers 87
Posts 6578
Boards Moderated 1
Alias Born 09/18/2009

Re: ZenNavigator54 post# 42507

Friday, 05/10/2024 1:07:04 PM

Friday, May 10, 2024 1:07:04 PM

Post# of 42553
Unless Dale lost his Appeal, Humanigen is positioned to enter into a stock-for-stock merger with Taran. If Dale lost his Appeal, Taran could just outright buy Humanigen's shares. I don't think it's likely that Dale lost his Appeal, or Durrant would have submitted a Tender Offer, instead of an Asset Purchase Agreement.

You're not recognizing the value of Humanigen owning ~90% of the shares they issued, leaving a float of 192% of our OS. If lenz is gaining market access, whether through authorization or approval, or through its IND use by Gracell and Novavax, that news, announced with the Taran merger, will be the trigger for Humanigen to recall their loaned shares.